Top JPMorgan banker sees steady supply of Chinese health care IPOs, even amid valuation concerns


Source: scmp.com scmp.com

Key Topics in this News Article:

News Snapshot:

Chinese companies and investors raised US$18.3 billion from 77 new and secondary listings globally last year, according to Refinitiv It is debatable whether record-high valuations can hold as investors chase a scarce supply of targets, says Fang Min of Warburg Pincus China’s health care industry, the world’s second largest, will see a sustained increase in stock offerings after registering record-high transactions and valuations in 2020, a senior JPMorgan Chase banker said. China’s health care industry, the world’s second largest, will see a sustained increase in stock offerings after registering record-high transactions and valuations in 2020, a senior JPMorgan Chase banker...